(Q39389224)

11 September 2017

WNT6 is a novel target gene of caveolin-1 promoting chemoresistance to epirubicin in human gastric cancer cells (English)

1 reference

11 September 2017

C Röcken

10

0 references

author name string

G Yuan

1

1 reference

11 September 2017

I Regel

2

1 reference

11 September 2017

F Lian

3

1 reference

11 September 2017

T Friedrich

4

1 reference

11 September 2017

I Hitkova

5

1 reference

11 September 2017

R D Hofheinz

6

1 reference

11 September 2017

P Ströbel

7

1 reference

11 September 2017

R Langer

8

1 reference

11 September 2017

G Keller

9

1 reference

11 September 2017

W Zimmermann

11

1 reference

11 September 2017

R M Schmid

12

1 reference

11 September 2017

M P A Ebert

13

1 reference

11 September 2017

E Burgermeister

14

1 reference

11 September 2017

language of work or name

English

0 references

publication date

27 February 2012

1 reference

11 September 2017

1 reference

11 September 2017

32

1 reference

11 September 2017

3

1 reference

11 September 2017

375-387

1 reference

https://scigraph.springernature.com/pub.10.1038/onc.2012.40

11 September 2017

0 references

cites work

Gastric cancer epidemiology and risk factors

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.40

Global patterns of cancer incidence and mortality rates and trends

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.40

Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.40

Capecitabine and oxaliplatin for advanced esophagogastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.40

The Wnt signaling pathway in development and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.40

Wnt/beta-catenin signaling in development and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.40

Activation of beta-catenin in epithelial and mesenchymal hepatoblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.40

Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.40

Aberrant Wnt/beta-catenin signaling can induce chromosomal instability in colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.40

Diverse mechanisms of Wnt activation and effects of pathway inhibition on proliferation of human gastric carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.40

Selective activation mechanisms of Wnt signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.40

Wnt3/RhoA/ROCK signaling pathway is involved in adhesion-mediated drug resistance of multiple myeloma in an autocrine mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.40

The Wnt receptor FZD1 mediates chemoresistance in neuroblastoma through activation of the Wnt/beta-catenin pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.40

Activation of Wnt/beta-catenin signalling pathway induces chemoresistance to interferon-alpha/5-fluorouracil combination therapy for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.40

FGF10 signaling controls stomach morphogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.40

Wnt6 induces the specification and epithelialization of F9 embryonal carcinoma cells to primitive endoderm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.40

WNT10A and WNT6, clustered in human chromosome 2q35 region with head-to-tail manner, are strongly coexpressed in SW480 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.40

Caveolae: from cell biology to animal physiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.40

The multiple faces of caveolae

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.40

A role for lipid shells in targeting proteins to caveolae, rafts, and other lipid domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.40

Caveolin-1 in oncogenic transformation, cancer, and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.40

Differential expression and function of caveolin-1 in human gastric cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.40

Role of caveolin-1 in etoposide resistance development in A549 lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.40

Caveolin-1 and cancer multidrug resistance: coordinate regulation of pro-survival proteins?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.40

Upregulation of caveolin-1 and CD147 expression in nasopharyngeal carcinoma enhanced tumor cell migration and correlated with poor prognosis of the patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.40

The Ras inhibitors caveolin-1 and docking protein 1 activate peroxisome proliferator-activated receptor γ through spatial relocalization at helix 7 of its ligand-binding domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.40

Identification of genes with differential expression in acquired drug-resistant gastric cancer cells using high-density oligonucleotide microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.40

Biochemical analysis of murine Wnt proteins reveals both shared and distinct properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.40

Efficient eradication of subcutaneous but not of autochthonous gastric tumors by adoptive T cell transfer in an SV40 T antigen mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.40

Histomorphology and grading of regression in gastric carcinoma treated with neoadjuvant chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.40

Helping Wingless take flight: how WNT proteins are secreted

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.40

Regulated portals of entry into the cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.40

Caveolin is necessary for Wnt-3a-dependent internalization of LRP6 and accumulation of beta-catenin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.40

Wnt induces LRP6 signalosomes and promotes dishevelled-dependent LRP6 phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.40

Caveolin-1 expression inhibits Wnt/beta-catenin/Lef-1 signaling by recruiting beta-catenin to caveolae membrane domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.40

Suppression of gastric cancer cell growth by targeting the beta-catenin/T-cell factor pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.40

Regulator of G protein signaling 6 mediates doxorubicin-induced ATM and p53 activation by a reactive oxygen species-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.40

ATM and p53 regulate FOXM1 expression via E2F in breast cancer epirubicin treatment and resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.40

p53 regulates caveolin gene transcription, cell cholesterol, and growth by a novel mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.40

Axin determines cell fate by controlling the p53 activation threshold after DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.40

A genomewide study identifies the Wnt signaling pathway as a major target of p53 in murine embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.40

Caveolin-1 in tumor progression: the good, the bad and the ugly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.40

Laminin gamma2 mediates Wnt5a-induced invasion of gastric cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.40

Comprehensive DNA methylation profiling in a human cancer genome identifies novel epigenetic targets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.40

Caveolin-1 inhibits anchorage-independent growth, anoikis and invasiveness in MCF-7 human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.40

Caveolin-1 inhibits cell detachment-induced p53 activation and anoikis by upregulation of insulin-like growth factor-I receptors and signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.40

Expression of carbonic anhydrase 9 at the invasion front of gastric cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.40

Increased beta-catenin mRNA levels and mutational alterations of the APC and beta-catenin gene are present in intestinal-type gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.40

A novel partial agonist of peroxisome proliferator-activated receptor-gamma (PPARgamma) recruits PPARgamma-coactivator-1alpha, prevents triglyceride accumulation, and potentiates insulin signaling in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.40

Significance of Histopathological Tumor Regression After Neoadjuvant Chemotherapy in Gastric Adenocarcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.40

Up-regulation of caveolae and caveolar constituents in multidrug-resistant cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.40

Upregulation of caveolin-1 and caveolae organelles in Taxol-resistant A549 cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.40

Caveolin-1 expression is significantly associated with drug resistance and poor prognosis in advanced non-small cell lung cancer patients treated with gemcitabine-based chemotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.40

Increased expression of caveolin-1 and microvessel density correlates with metastasis and poor prognosis in clear cell renal cell carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.40

Caveolin-1 in meningiomas: expression and clinico-pathological correlations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.40

Caveolin-1 overexpression is associated with aggressive prostate cancer recurrence

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.40

A transgenic mouse line that develops early-onset invasive gastric carcinoma provides a model for carcinoembryonic antigen-targeted tumor therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.40

Expression of Wnt-5a is correlated with aggressiveness of gastric cancer by stimulating cell migration and invasion

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2012.40

31 March 2020

Identifiers

DOI

10.1038/ONC.2012.40

1 reference

Dimensions Publication ID

11 September 2017

0 references

1 reference